Use of Professional CGM in T2DM Patients with Low Socioeconomic Status

被引：1
|
作者：
Mehrotra, Neha
Sistla, Divya
Korytkowski, Mary T.
Mon, Sann
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-969-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
969-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Significance of Hypoglycemia in T2DM Patients in Primary Care
    Lavernia, Frank
    Tomky, Donna M.
    Mcghee, Theresa A.
    Dex, Terry
    Dalal, Mehul
    Frimpter, Jeffrey
    Zhou, Wei
    Stewart, John
    Vlajnic, Aleksandra
    DIABETES, 2014, 63 : A562 - A563
  • [32] Surgical or medical therapy for patients with obesity and T2DM?
    Sten Madsbad
    Jens J. Holst
    Nature Reviews Endocrinology, 2016, 12 : 500 - 502
  • [33] Metabolic effects of the Atkins' diet in patients with T2DM
    Sargrad, K
    Homko, C
    Mozzoli, M
    Boden, G
    DIABETES, 2003, 52 : A387 - A387
  • [34] Early life malnutrition and risk of T2DM adulthood: evidence from the lower socioeconomic status of northwest Chinese population
    Shi, Hongjuan
    Yang, Danyu
    Ma, Ling
    Cheng, Yin
    Liu, Yining
    Ma, Jinyu
    Tong, Huitian
    Shi, Chao
    FRONTIERS IN NUTRITION, 2024, 11
  • [35] Predicting renal function decline in patients with T2DM
    George Jerums
    Richard J. MacIsaac
    Nature Reviews Endocrinology, 2014, 10 : 381 - 382
  • [36] Surgical or medical therapy for patients with obesity and T2DM?
    Madsbad, Sten
    Holst, Jens J.
    NATURE REVIEWS ENDOCRINOLOGY, 2016, 12 (09) : 500 - 502
  • [37] Rationale for exercise in T2DM patients with depression and/or obesity
    Kavookjian, Jan
    DIABETES, 2008, 57 : A305 - A305
  • [38] Statins: liver safety in patients with NASH, T2DM
    Reactions Weekly, 2017, 1656 (1) : 13 - 13
  • [39] Achieving target BP and lipids in patients with T2DM
    Hood, RC
    DIABETES, 2002, 51 : A485 - A485
  • [40] Renoprotective effects of dulaglutide in patients with T2DM and CKD
    Charlotte M. Sorensen
    Jens J. Holst
    Nature Reviews Nephrology, 2018, 14 : 659 - 660
12345